At the Stem Cells Transplant Institute, we offer mesenchymal stem cell (MSC) therapy for anti-aging to support cellular health, reduce inflammation, and promote overall wellness and vitality.
As we age, our cells gradually lose efficiency in repairing damage, managing inflammation, and supporting tissue health. This can contribute to decreased energy, slower recovery, increased inflammation, and changes in skin, muscle, and joint function. Scientists are not sure about the exact cause of aging, but many agree that cumulative exposure to harmful factors and the gradual buildup of cellular damage can contribute to aging over time.
According to the World Health Organization (2023), global life expectancy has increased by over 6 years in the last two decades, and the demand for healthy aging strategies continues to rise worldwide.
Although no one can live forever, our goal is to support healthier aging processes and overall wellness through research-based regenerative care.
Stem Cells Transplant Institute in Costa Rica offers MSC-based cellular rejuvenation programs for adults who wish to support healthier aging through a regenerative approach. Treatment is delivered in San José within a certified medical facility with physician supervision.
Mesenchymal stem cell (MSC) protocols are delivered as part of a comprehensive evaluation focused on metabolic function, inflammatory status, and overall health profile. The objective is to support physiological balance rather than to replace standard medical care.
Patients from the United States, Canada, and Europe travel to San José to access physician-supervised regenerative wellness programs. San José has direct flights from most North American cities, and programs are generally completed in 3-5 days. Many patients extend the trip, as it is one of the world’s best places to spend a few extra days.
Prior to scheduling treatment, all patients undergo a detailed medical assessment to determine candidacy. This evaluation typically includes: a blood panel, metabolic markers, and inflammatory indicators. The treatment protocols will be created based on clinical findings and medical evaluation, setting realistic expectations and timelines.
Research suggests mesenchymal stem cells may modulate the immune system, help reduce inflammation and release factors that support tissue maintenance and repair processes associated with cellular wellness.
We believe mesenchymal stem cells may help support physiological processes relevant to healthy aging, because organs such as the skin, brain heart, liver, joints, and kidneys can be influenced by inflammatory balance and tissue-repair signaling. Finally, supporting inflammatory balance may contribute to overall wellness and function as we age.
Stem cell therapy is considered complementary and works alongside healthy lifestyle practices, good nutrition, appropriate exercise, and medical guidance.
Evidence remains preliminary and ongoing trials are required to confirm these effects.
MSCs naturally release signaling molecules that may help calm chronic, age-related inflammation—often called “inflammaging.” (Fafián-Labora & O’Loghlen, 2020)
MSC-derived growth factors may help support the body’s intrinsic repair processes in skin, joints, and soft tissues. (Mahmoudi et al., 2019)
Stem cells secrete extracellular vesicles that may help support intercellular communication and functional signaling in aging cells. (Phinney & Pittenger, 2017)
Some studies suggest MSCs may help support cellular energy pathways and reduce oxidative stress. (Zhang et al., 2020)
Although individual results vary, studies and clinical observations suggest potential changes in the following areas:
*These percentages are not guarantees and should not be interpreted as typical results. They are presented for informational context only. Ranges reflect relative changes reported from baseline in selected research settings, using study-specific assessments. They do not represent a standardized endpoint, and they do not predict individual outcomes. Findings across the literature are heterogeneous (cell source, dose, route, patient populations, follow-up duration, and outcome measures vary), and some evidence may be preliminary, observational, or not directly comparable. No therapy guarantees changes in appearance, energy, cognition, or aging processes. Results—if any—may be modest, temporary, or absent. Clinical evidence remains preliminary, and ongoing research continues to evaluate the magnitude, consistency, and durability of these observations.”
Published studies and patient-reported outcomes suggest that improvements after mesenchymal stem cell (MSC) therapy for anti aging may develop gradually over time. These timelines are illustrative summaries rather than predictions, and individual responses vary significantly.
*These timelines summarize patterns reported across selected published studies and patient observations. They are not specific predictions, and they do not represent expected outcomes for any individual patient. Individual experiences vary considerably, and some patients may experience minimal or no improvement. Evidence for MSC therapy for anti-aging remains preliminary, and larger controlled clinical observations are needed. All timelines should be interpreted as exploratory and non-confirmatory.
No. Stem cells cannot reverse aging. They may help support physiological processes associated with healthier aging and overall wellness, but they are not an anti-aging cure and do not stop or reverse the biological aging process.
Everyone is different. Some studies report wellness-related changes that may persist for several months, while others show modest or variable effects. MSC therapy is considered supportive, not permanent and the presence, timing, or duration of any changes cannot be predicted or guaranteed.
The Stem Cell Transplant Institute uses clinically established sources of mesenchymal stem cells (MSCs), selected based on individual medical assessment and applicable regulatory standards. Cell sourcing, processing, and administration are performed according to established safety and quality requirements.
Any wellness-focused changes, if they occur, are often gradual and may take weeks to several months. Individual experiences vary, and the presence, timing, or degree of any changes cannot be predicted or guaranteed.
Stem cell therapy using MSCs has shown a generally favorable safety profile in clinical studies when appropriately sourced, processed, and administered.
However, all medical procedures carry potential risks, which may include:
Serious adverse effects are uncommon but remain possible. Every patient undergoes medical screening to determine whether the therapy is appropriate, and emergency medical support is available on-site.
Scientific review exploring how extracellular vesicles influence aging processes, cellular communication, and tissue regeneration pathways.
View published study
Clinical review discussing therapeutic applications of stem cells in anti-aging treatments and their regenerative potential for skin and systemic health.
View published study
Scientific review describing how mesenchymal stem cell-derived exosomes may support regenerative medicine through cell-free therapeutic mechanisms.
View published study
Research article examining biological mechanisms of MSC aging and potential rejuvenation strategies to enhance regenerative therapeutic effectiveness.
View published study
San José, Costa Rica
info@stemcellstransplantinstitute.com
+1 888 785-4170
